The appearance and
quick spread of the new severe acute respiratory
syndrome coronavirus disease, COVID-19, brought major societal challenges.
Importantly, suitable medical diagnosis procedures and smooth clinical
management of the disease are an emergent need, which must be anchored
on novel diagnostic methods and devices. Novel molecular diagnostic
tools relying on nucleic acid amplification testing have emerged globally
and are the current gold standard in COVID-19 diagnosis. However,
the need for widespread testing methodologies for fast, effective
testing in multiple epidemiological scenarios remains a crucial step
in the fight against the COVID-19 pandemic. Biosensors have previously
shown the potential for cost-effective and accessible diagnostics,
finding applications in settings where conventional, laboratorial
techniques may not be readily employed. Paper- and cellulose-based
biosensors can be particularly relevant in pandemic times, for the
renewability, possibility of mass production with sustainable methodologies,
and safe environmental disposal. In this review, paper-based devices
and platforms targeting SARS-CoV-2 are showcased and discussed, as
a means to achieve quick and low-cost PoC diagnosis, including detection
methodologies for viral genomic material, viral antigen detection,
and serological antibody testing. Devices targeting inflammatory markers
relevant for COVID-19 are also discussed, as fast, reliable bedside
diagnostic tools for patient treatment and follow-up.
This review provides a fresh overview of non-canonical amino acids and their applications in the design of peptidomimetics. Non-canonical amino acids appear widely distributed in nature and are known to enhance the stability of specific secondary structures and/or biological function. Contrary to the ubiquitous DNA-encoded amino acids, the structure and function of these residues are not fully understood. Here, results from experimental and molecular modelling approaches are gathered to classify several classes of non-canonical amino acids according to their ability to induce specific secondary structures yielding different biological functions and improved stability. Regarding side-chain modifications, symmetrical and asymmetrical α,α-dialkyl glycines, Cα to Cα cyclized amino acids, proline analogues, β-substituted amino acids, and α,β-dehydro amino acids are some of the non-canonical representatives addressed. Backbone modifications were also examined, especially those that result in retro-inverso peptidomimetics and depsipeptides. All this knowledge has an important application in the field of peptidomimetics, which is in continuous progress and promises to deliver new biologically active molecules and new materials in the near future.
A new d-erythrose 1,3-dioxane derivative was synthesized from d-glucose and found to be a highly stereoselective template as a dipolarophile. Different 1,3-dipoles of allenyl-type were employed, giving different regioselectivities, depending on its nature; the regioselectivity is complete with alkyl azides and phenyldiazomethane, but is inexistence with nitrile oxides. Computational studies were performed to understand the mechanisms of cycloadditions. All the studied cycloadditions were found to be concerted involving small free activation energies and are all exoenergonic. The stereoselectivity is due to a combined result of the steric effect H-8a and the hyperconjugative effect of the *C-O to the incoming 1,3-dipole. The regioselectivity observed in alkyl azides and phenyldiazomethane is mostly dependent on the distortion effect during the cycloaddition process. This distortion effect is however higher in the alkyl azide compounds than in phenyldiazomethane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.